{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:38:49Z","timestamp":1787002729042,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM129783"],"award-info":[{"award-number":["R01GM129783"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41397-022-00266-8","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T21:02:23Z","timestamp":1644958943000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-8949","authenticated-orcid":false,"given":"Jennifer L.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna O.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-4780","authenticated-orcid":false,"given":"Neil","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Eveleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Pastinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jid.2017.12.015","volume":"138","author":"N Frey","year":"2018","unstructured":"Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J. Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study. J Invest Dermatol. 2018;138:1207\u20139.","journal-title":"J Invest Dermatol"},{"key":"266_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/cid\/ciu126","volume":"58","author":"YF Lin","year":"2014","unstructured":"Lin YF, Yang CH, Sindy H, Lin JY, Rosaline Hui CY, Tsai YC, et al. Severe cutaneous adverse reactions related to systemic antibiotics. Clin Infect Dis. 2014;58:1377\u201385.","journal-title":"Clin Infect Dis"},{"key":"266_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.20800","volume":"42","author":"E Bjornsson","year":"2005","unstructured":"Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481\u20139.","journal-title":"Hepatology"},{"key":"266_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2796.1990.tb00245.x","volume":"228","author":"M Keisu","year":"1990","unstructured":"Keisu M, Wiholm BE, Palmblad J. Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years\u2019 experience of the Swedish spontaneous reporting system. J Intern Med. 1990;228:353\u201360.","journal-title":"J Intern Med"},{"key":"266_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/clpt.2011.79","volume":"89","author":"M Pirmohamed","year":"2011","unstructured":"Pirmohamed M, Friedmann PS, Molokhia M, Loke YK, Smith C, Phillips E, et al. Phenotype standardization for immune-mediated drug-induced skin injury. Clin Pharm Ther. 2011;89:896\u2013901.","journal-title":"Clin Pharm Ther"},{"key":"266_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/hep.31258","volume":"73","author":"YJ Li","year":"2021","unstructured":"Li YJ, Phillips E, Dellinger A, Nicoletti P, Schutte R, Li D, et al. HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury. Hepatology. 2021;73:268\u201381.","journal-title":"Hepatology"},{"key":"266_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","volume":"147","author":"CW Wang","year":"2021","unstructured":"Wang CW, Tassaneeyakul W, Chen CB, Chen WT, Teng YC, Huang CY, et al. Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. J Allergy Clin Immunol. 2021;147:1402\u201312.","journal-title":"J Allergy Clin Immunol"},{"key":"266_CR8","doi-asserted-by":"crossref","unstructured":"Miller JO, Taylor J, Goldman JL. Severe acute respiratory failure in healthy adolescents exposed to trimethoprim-sulfamethoxazole. Pediatrics. 2019;143:e20183242.","DOI":"10.1542\/peds.2018-3242"},{"key":"266_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.202009-3421LE","volume":"203","author":"JO Miller","year":"2021","unstructured":"Miller JO, Shih AR, Mino-Kenudson M, Taylor MS, Goldman JL. Trimethoprim-sulfamethoxazole-associated fulminant respiratory failure in children and young adults. Am J respiratory Crit care Med. 2021;203:918\u201321.","journal-title":"Am J respiratory Crit care Med"},{"key":"266_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharm Ther. 1981;30:239\u201345.","journal-title":"Clin Pharm Ther"},{"key":"266_CR11","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FF, McCabe A, Santos E, Jones J, Takeshita L, Ortega-Rivera ND, et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 2020;48:D783\u20138.","journal-title":"Nucleic Acids Res"},{"key":"266_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/clpt.2008.89","volume":"84","author":"DM Roden","year":"2008","unstructured":"Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharm Ther. 2008;84:362\u20139.","journal-title":"Clin Pharm Ther"},{"key":"266_CR13","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3389\/fimmu.2017.01815","volume":"8","author":"A Larjo","year":"2017","unstructured":"Larjo A, Eveleigh R, Kilpelainen E, Kwan T, Pastinen T, Koskela S, et al. Accuracy of programs for the determination of human leukocyte antigen alleles from next-generation sequencing data. Front Immunol. 2017;8:1815.","journal-title":"Front Immunol"},{"key":"266_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/gm409","volume":"5","author":"AK Daly","year":"2013","unstructured":"Daly AK. Pharmacogenomics of adverse drug reactions. Genome Med. 2013;5:5.","journal-title":"Genome Med"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.humimm.2020.10.004","volume":"82","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FF, McCabe A, Melo Dos Santos EJ, Jones AR, Middleton D. A snapshot of human leukocyte antigen (HLA) diversity using data from the Allele Frequency Net Database. Hum Immunol. 2020;82:496\u2013504.","journal-title":"Hum Immunol"},{"key":"266_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/gm350","volume":"4","author":"A Alfirevic","year":"2012","unstructured":"Alfirevic A, Gonzalez-Galarza F, Bell C, Martinsson K, Platt V, Bretland G, et al. In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med. 2012;4:51.","journal-title":"Genome Med"},{"key":"266_CR17","unstructured":"Abacavir sulfate drug insert. 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020977s024,020978s028lbl.pdf."},{"key":"266_CR18","unstructured":"Carbamazepine drug insert. 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/016608s101,018281s048lbl.pdf."},{"key":"266_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev-pharmtox-010818-021818","volume":"59","author":"JH Karnes","year":"2019","unstructured":"Karnes JH, Miller MA, White KD, Konvinse KC, Pavlos RK, Redwood AJ, et al. Applications of Immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions. Annu Rev Pharm Toxicol. 2019;59:463\u201386.","journal-title":"Annu Rev Pharm Toxicol"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00266-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:28:25Z","timestamp":1648805305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00266-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1038\/s41397-022-00266-8","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"23 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EJP reports grants from National Institutes of Health (P50GM115305, R01HG010863, R01AI152183, R21AI139021, U01AI154659) and from the National Health and Medical Research Council of Australia. She receives Royalties from Uptodate and consulting fees from Janssen, Vertex, Biocryst and Regeneron. She is co-director of IIID Pty Ltd that holds a patent for <i>HLA-B*57:01<\/i> testing for abacavir hypersensitivity, and has a patent pending for Detection of Human Leukocyte Antigen-A*32:01 in connection with Diagnosing Drug Reaction with Eosinophilia and Systemic Symptoms without any financial remuneration and not directly related to the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}